WO2007090433A2 - Purified oxides with novel morphologies formed from ti-alloys - Google Patents

Purified oxides with novel morphologies formed from ti-alloys Download PDF

Info

Publication number
WO2007090433A2
WO2007090433A2 PCT/EP2006/002239 EP2006002239W WO2007090433A2 WO 2007090433 A2 WO2007090433 A2 WO 2007090433A2 EP 2006002239 W EP2006002239 W EP 2006002239W WO 2007090433 A2 WO2007090433 A2 WO 2007090433A2
Authority
WO
WIPO (PCT)
Prior art keywords
implant according
oxide
bone implant
bone
layer
Prior art date
Application number
PCT/EP2006/002239
Other languages
French (fr)
Other versions
WO2007090433A8 (en
WO2007090433A3 (en
Inventor
Philippe Kern
Olivier Zinger
Original Assignee
Plus Orthopedics Ag
Schweizerische Material Prüfungs- Und Forschungsanstalt Empa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plus Orthopedics Ag, Schweizerische Material Prüfungs- Und Forschungsanstalt Empa filed Critical Plus Orthopedics Ag
Publication of WO2007090433A2 publication Critical patent/WO2007090433A2/en
Publication of WO2007090433A8 publication Critical patent/WO2007090433A8/en
Publication of WO2007090433A3 publication Critical patent/WO2007090433A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C14/00Alloys based on titanium
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23FNON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
    • C23F1/00Etching metallic material by chemical means
    • C23F1/10Etching compositions
    • C23F1/14Aqueous compositions
    • C23F1/16Acidic compositions
    • C23F1/26Acidic compositions for etching refractory metals
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/024Anodisation under pulsed or modulated current or potential
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/026Anodisation with spark discharge
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/26Anodisation of refractory metals or alloys based thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/3082Grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00592Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
    • A61F2310/00598Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
    • A61F2310/00616Coating made of titanium oxide or hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/112Phosphorus-containing compounds, e.g. phosphates, phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43Hormones, e.g. dexamethasone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/04Anodisation of aluminium or alloys based thereon
    • C25D11/06Anodisation of aluminium or alloys based thereon characterised by the electrolytes used
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25DPROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
    • C25D11/00Electrolytic coating by surface reaction, i.e. forming conversion layers
    • C25D11/02Anodisation
    • C25D11/04Anodisation of aluminium or alloys based thereon
    • C25D11/16Pretreatment, e.g. desmutting

Definitions

  • Fig. 1 SEM micrographs of etched Ti (a), Ti6A17Nb (b) and Ti6A14V (c) surfaces showing the microstructures of the used substrates.
  • the bright phase in (b) and (c) corresponds to the ⁇ phase.
  • Fig. 4a The cross-section of a focused ion beam (FIB) milled oxide on TiAlNb with a porous morphology, grown in 0.5 M HS at 170 V and corresponding to Fig. 3b, is presented in Fig. 4a.
  • Fig. 4b shows the cross-section of an oxide with a worm-like morphology on the same substrate, but grown in 0.5 M HSHP at 200 V (Fig. 3e).
  • Fig. 5a The spectra in Fig. 5a for Ti anodized at 165 V in 0.5 M HS can be ascribed to a mixture of anatase and rutile, with anatase being the dominant phase. After spark anodisation of Ti at 185 V in the acid mixture, anatase structure (Fig. 5b) without any signs of rutile was observed. A strong rutile signature was found for TiAlNb oxidized at 170 V in 0.5 M HS (Fig. 5c). The spectra contains also anatase and brookite signals, with a strong brookite line at 157 cm "1 , being too far from 144 cm "1 to be ascribed to anatase.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Metallurgy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Catalysts (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The behaviour of the α/β Ti6A14V and Ti6A17Nb alloys and of the α, c.p. Ti upon spark anodisation in H2SO4, H3PO4 and mixtures of these acids is presented. Chemical depth profiling reveals purified oxides with respect to the substrate alloying elements. This is particularly pronounced on Ti-alloys spark anodized in H2SO4ZH3PO4 mixtures, with Al decreasing continuously towards the surface, and V and Nb remaining hardly detectable in the outermost 200 nm. In addition, the incorporation of S was significantly reduced in mixed electrolytes, while about 8 at-% P was incorporated. A novel oxide morphology with 'worm-like' features in the μm-range, very different from well-known nano/micro-porous oxides, was found in mixed electrolytes under optimized conditions. A similar but more porous-like structure is formed on c.p. Ti. Raman measurements indicate the presence of mixed anatase, rutile and brookite phases on anodized Ti-alloys. Bond strengths of 34 MPa for worm-like and 40-50 MPa for nano/micro- porous morphologies as well as excellent abrasion behaviour characterized the mechanical properties of the oxides. The compatibility of grit-blasting and etching of surfaces with the spark anodisation process for creating multi-topography surfaces is confirmed.

Description

Purified Oxides with Novel Morphologies formed from Ti-alloys
The current invention relates to a purified oxide which is possessed of a novel in surface morphology, and a method of producing the same from a Ti-alloy mixed with sulphuric and phosphoric acid electrolytes.
Background to the Invention
Spark anodization of c.p.-titanium (commercially pure) for biomedical surface preparation, also know as micro(-)arc oxidation (MAO), micro-plasma oxidation (MPO), anodic spark deposition (ASD) and plasma electrolyte oxidation (PEO), has been the subject of numerous recent scientific studies. Considerably less data is available on spark anodisation of the Ti6A14V alloy, and about the increasingly used Ti6A17Nb alloy. Spark anodisation of Ti or Ti- alloys under appropriate conditions can lead to rough and porous anodic films which are up to several tens of micrometers thick, whilst at the same time being free of sharp edges. The high porosity opens up new possibilities with regard to incorporation of bioactive or bioresorbable species and the preparation of "bioactive surfaces", which is particularly interesting for implant applications where accelerated bone in-growth is important. In 1986, Branemark and co-workers published the patent US 4,330,891, describing a micro-pitted (Ti)-surface with pore size between 10-1000 nm, ideally equal or smaller than 300 nm, in a TiO2 rutile layer. Without further specification, it is evident that such surfaces were produced using a spark anodisation process.
The electrochemical oxide growth on cp-titanium in several acid and alkaline electrolytes, addressing anodic forming voltage, forming rate and growth constant, was studied by SuI et al. [SuI YT, Johansson CB, Jeong Y, Albrektsson T. The electrochemical oxide growth behaviour on titanium in acid and alkaline electrolytes. Med Eng & Phys 2001 ;23: 329-346]. Working in acetic acid, the same authors found that spark anodized turned surfaces, with an oxide thickness more than 600 nm, demonstrated a stronger histomorphometrical bone response and a more pronounced osteoinductivity compared to non-oxidized control implants after 6 weeks of insertion in rabbit bone. By comparing removal torque values of implants with different surface oxide chemistry resulting from anodisation in sulphuric acid, phosphoric acid and calcium containing electrolytes, it was concluded that surface chemistry and topography play an important role in the bone response to oxidized implants. The possibility of biochemical bonding between P and Ca containing Ti-oxides and bone was pointed out. WO 02/096475 was based on this data, which further claimed Ti-alloys, describing a spark anodized layer containing Ca, P or S and having a double layer structure of an upper porous layer and lower compact barrier layer. By comparing spark anodized (H2SO4) Ti surfaces, subjected to a post thermal treatment (600°C), to "bioactive" Ti surfaces produced by alkali immersion and heat treatment, Liang and co-workers [Liang B, Fujibayashi S, Neo M, Tamura J, Kim HM, Uchida M, Kokubo T, Nakamura T. Histological and mechanical investigation of the bone-bonding ability of anodically oxidized titanium in rabbits. Biomaterials 2003;24 (27): 4956-4966] observed faster bone-in-growth and higher failure loads on anodized surfaces in the early stage of implantation. The failure in improving bone-bonding ability compared to the chemically treated surfaces at later implantation stages was attributed to the low oxide porosity and hence, the superficial apatite-like deposition into the pores. The importance of the presence of crystalline TiO2 phase on the bioactivity of sulphuric acid anodized titanium has also been underlined. An increase of anatase and even more significantly, rutile phase, obtained by either applying a higher anodisation potential or a post heat-treatment, resulted in accelerated apatite formation upon immersion in simulated body fluid (SBF). This has been attributed to the matching structure of rutile (101) and apatite (0004) planes, acting as nuclei for apatite crystal growth. JP 2003 190272, describes the formation of a coating with high bioaffmity on Ti and Ti-alloys by combined anodisation and post heat treatment at around 600°C. A very similar approach of anodisation (phosphate solution) and heat treatment for titanium or titanium-based micro-alloy containing at least 98 w-% Ti is discussed in US 5,354,390.
Considerable effort has been made to incorporate Ca and P species during spark anodisation of c.p.-Ti surfaces for a further enhancement of the bioactivity of titanium implants, without having the mechanical drawbacks of hydroxyapatite (HA) coatings. US 4,846,837 describes a process of spark anodizing a previously roughened (100-400 μm) implant metal in a
solution containing CaP, leading to 5 to 30 μm thick oxides having a CaP gradient throughout the
oxide. Electrolytes containing β-glycerophosphate (β-GP) and calcium acetate (CA) have been used and the anodisation process combined with a post-hydrothermal treatment at 300°C, leading to HA precipitation on the anodic oxide film, as described in US 478,237. JPl 1 043 799 and JP 2000 178791 describe a method for anodizing Ti in an electrolyte containing a glycerophosphate and a metal acetate followed by a hydrothermal treatment in water or steam, during which phosphorus or sulphur and the added metal dissolve and leave an adjustable pore size and highly wettable films. Working in a very similar electrolyte, WO 2004/000378 describes a biomimetic surface and a spark process for Ti, Ta and their alloys with incorporation of Ca and P. The 3-step process consists of spark anodisation in Ca-GP, a second spark deposition in Ca(OH)2 followed by immersion in NaOH. By pulsed anodisation in β-GP and CA containing solutions, oxides containing CaTiO3, β-Ca2P2O7 and α-Ca3(Pθ4)2 have been produced above 450 V incorporated in a mixed anatase/rutile matrix with Ca/P ratios between 1.3-1.8. Without the need for hydrothermal treatment, these oxides show the capability to induce bone-like apatite in SBF. Working under very similar conditions, an increase of ALP activity and a decrease of cell proliferation rate has been found with increasing anodisation potential. Via a complex of Ca with EDTA and working at pH 14, a Ca/P ratio up to 1.3 has been seen. The fully or partly soluble CaP phases were embedded in a matrix of amorphous and anatase TiO2, with further evidence that this process can be applied to Ti6A14V and Ti6A17Nb alloys. This anodisation procedure is described in WO 02/078759 mentioning pore densities between 104-108 /mm2and Ca/P ratios from 0.5 to 2.0.
Porous anodized films on Ti6A14V α/β alloy have been initially found advantageous for bonding purposes, and more recently for wear- and corrosion-resistant applications, biocidal or catalytic properties, sensors and also as biomedical coatings.
Spark anodisation of Ti6A14V in aluminate and silicate solutions containing Na2SiO3- KOH-(NaPOs)6, Na2SiO3-KOH-(NaPO3)O-NaAlO2, (NaP03)6-NaF-NaA102 and NaAlO2 has been shown to provide thick and wear-resistant porous coatings. Coating hardnesses of 8.54 GPa up to 13 GPa were reported due to the presence of hard TiAl2O5 phase within TiO2 rutile matrix. Pulsed anodisation with 8% duty cycle was found to be advantageous compared with constant voltage, in terms of creating smaller pores in anodized films and less apparent cracking. A good combination of wear- and corrosion resistance of duplex Cr(N)ATiO2 coatings formed on Ti6A14V by microarc oxidation in sodium phosphate combined with magnetron sputtered Cr(N) as top layer has also been observed. By anodising Ti-alloys in vanadate-tungstate and vanadate- tungstate-phosphates containing solutions, oxides enriched with P, V and W having catalytic properties have been prepared. Of interest for sensor applications, nano-crystalline rutile films on Ti6A14V substrate via spark anodisation in aqueous Na2CO3 solution have been prepared and their mechanical properties investigated.
Using a 2-step process, spark anodisation of TΪ6A14V in a solution of phosphate salt has been combined with anodic electrophoresis, creating a HA-TiO2 coating with a dense TiO2 film as an inner layer and HA as top layer. A combination of bioactivity, chemical stability and mechanical integrity was reported. Incorporation of Ca and P during spark anodisation of TΪ6A14V as well as the effect of electrolyte composition and anodisation potential on structure, Ca/P ratio and film morphology have been studied. Using a combination of anodisation and hydrothermal treatment as known for c.p.-Ti, oxides containing fine HA or apatite crystals on Ti6A14V alloy were prepared. Working under alkaline conditions, the TiMAX® process for implant surfaces, property of DePuy ACE, USA, is based on the anodisation of Ti6A14V material followed by a mechanical post-treatment, resulting in a high fatigue strength.
The Ti6A17Nb alpha-beta alloy has been increasingly used for the production of cementless femoral stems and elastically deformable cup shells, often in combination with an oxygen diffusion hardening process reaching a surface hardness up 1200 HV. Investigations of the composition of passivated Ti6A17Nb surfaces, have shown an incorporation of Al and Nb in the oxide layer, with an enrichment of Al in the α and Nb in the β phase, reflecting the distribution in the underlying substrate. By comparing the electrochemical behaviour of air formed passive layers and anodic layers on cp-Ti, Ti6A14V and Ti6A17Nb at different pH, a significantly lower donor density and a higher Faraday efficiency of oxide formation is found for Ti6A17Nb compared with the other materials. As such, in the case of an inflammatory response associated with a pH decrease in the surrounding tissue, a significant increase of the electronic conductivity is expected for Ti6A14V, but not for Ti6A17Nb, underlying the excellent biocompatibility of this alloy. Investigations of the corrosion resistance of both α/β alloys in 2M H2SO4 and 2M NaOH, the Ti6A17Nb alloy has shown a higher resistance in sulphuric acid but a lower resistance in sodium hydroxide. Using a multi-step chemical and thermal treatment, Ti6A17Nb oxide surfaces with good wettability, low ion release and moderate bone-like apatite induction ability have been prepared.
The chemical composition of anodic oxide films with respect to substrate alloying elements is of great importance for biomedical applications, since many alloying elements such as vanadium (V), aluminium (Al), nickel etc. are today recognized as undesired, harmful or even toxic (like V) elements in the body environment. There is an obvious need for a spark anodization process capable of decreasing the amount of alloying elements in the metal oxide layer. Only thin anodic oxides on Ti, Ti6A14V and Ti6A17Nb below the dielectric breakdown have been investigated. Based on XPS and SIMS depth profiles, a concentration level of typically 12-17 w-% Al, being significantly higher than expected from the bulk composition, was observed in native oxides on Ti6A14V and Ti6A17Nb. A SIMS depth profile through a Ti6A14V sample anodized in 1 M H2S04 at 45 V, well below the breakdown limit, showed a higher Al concentration in the oxide than in the metal, where V was depleted in the outermost surface region but enriched in the interfacial region [Lausmaa J. Mechanical, Thermal, Chemical and Electrochemical Surface Treatment of Titanium. In: Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in Medicine. Berlin & Heidelberg: Springer; 2001. p. 248-2551. An accumulation of alloying elements in the metal oxide layer compared to the metal substrate for native or spark-less anodized oxides on Ti-alloys is to be avoided with respect to the biocompatibility of such oxide layers. Today, no information is available on the distribution of alloying elements within spark anodized thick oxide layers on e.g. Ti-alloys, which is problematic when considering the aforementioned efforts to incorporate bioactive species within a "biocompatible" matrix.
In light of the above, there is still a great deal of scope for producing bio-compatible materials, which will give an enhanced morphology for incorporation of bone-growth stimulating agents. Further, such surfaces should preferentially be formed with a reduction in the amount of chemicals toxic to the human body, whilst additionally being formed in a repeatable and straightforward manner. Summary of the Invention
In order to address the problems as disclosed above, a material and method of production thereof is presented. The material is a metal alloy upon which an oxide layer is formed. The metal oxide layer and especially its outermost part contains significantly less alloying elements than are present in the metal alloy substrate. Preferentially, this oxide layer is continuous, and is partially intersected by multiple, narrow and elongate recesses in the surface. In another preferred embodiment, this metal oxide film, has a crystalline structure which is comprises a brookite.
Description of the Figures
Fig. 1. SEM micrographs of etched Ti (a), Ti6A17Nb (b) and Ti6A14V (c) surfaces showing the microstructures of the used substrates. The bright phase in (b) and (c) corresponds to the β phase.
Fig. 2. Current density and anodisation potential as a function of time during anodisation of Ti and Ti-alloys in (a) 0.5 M H2SO4 and (b) 0.5 M H2SO4 + 0.5 M H3PO4.
Fig. 3. SEM micrographs of selected anodisation conditions, (a) Ti / 0.5 M H2SO4/ 165 V, (b) TiAlNb / 0.5M H2SO4/ 170 V, (c) TiAlV / 0.5 M H2SO4/ 135 V, (d) Ti / 0.5 M H2SO4 + 0.5 M H3PO4/ 185 V, (e) TiAlNb / 0.5 M H2SO4 + 0.5 M H3PO4/ 200 V, (f) TiAlV / 0.5 M H2SO4 + 0.5 M H3PO4/ 190 V. The worm-like topography in (e) and (f) is very different from the nano/micro- porous oxides in (b) and (c).
Fig. 4. FIB cross-sections of spark anodised Ti6A17Nb substrates, (a) Micro/nano-porous morphology in 0.5 M H2SO4 at 170 V, (b) Worm-like oxide in 0.5 M H2SO4 + 0.5 M H3PO4at l70 V.
Fig. 5. Raman laser spectra of the spark anodized surfaces shown in Fig. 3. (a) Ti / 0.5 M H2SO4/
165 V, (b) Ti / 0.5 M H2SO4 + 0.5 M H3PO4/ 185 V, (c) TiAlNb / 0.5M H2SO4/ 170 V, (d) TiAlNb / 0.5 M H2SO4 + 0.5 M H3PO4/ 200 V5 (e) TiAlV / 0.5 M H2SO4/ 135 V, (f)
TiAlV / 0.5 M H2SO4 + 0.5 M H3PO4/ 190 V. Fig. 6. Quantitative GD-OES depth profile of a spark anodized Ti surface, (a) 0.5 M H2SO4/ 165
V, (b) 0.5 M H2SO4 + 0.5 M H3PO4/ 185 V. The inserts show a zoom of the first 200 nm.
At the intercept of Ti and O signals (Ti/O= 1 : 1 ), an oxide thickness of (a) 2.04 μm and (b)
1.67 μm is obtained. Fig. 7. Quantitative GD-OES depth profile of a spark anodized Ti6A17Nb surface, (a) 0.5 M
H2SO4/ 170 V, (b) 0.5 M H2SO4 + 0.5 M H3PO4/ 200 V. The inserts show a zoom of the first 200 nm. At the intercept of Ti and O signals (Ti/O=l:l), an oxide thickness of (a)
2.24 μm and (b) 3.14 μm is obtained. Fig. 8. Quantitative GD-OES depth profile of a spark anodized Ti6A14V surface, (a) 0.5 M
H2SO4/ 135 V, (b) 0.5 M H2SO4 + 0.5 M H3PO4/ 190 V. The inserts show a zoom of the first 200 nm. At the intercept of Ti and O signals (Ti/O=l:l), an oxide thickness of (a)
2.15 μm and (b) 3.14 μm is obtained. Fig. 9. Recombined micrograph from 4-quadrant BSE detector imaging showing a sandblasted, chemically etched and finally spark anodized Ti6A17Nb surface (0.5 M H2SO4 + 0.5 M
H3PO4/ 200 V).
Description of the Preferred Embodiment
1. Sample preparation and discussion of techniques
The following sections discuss the choice of materials and preparation of such. The methods disclosed in the preparation and certain equipment used, is given purely as an example of the technique. It would be clear to the skilled person, that other equipment options and different methods for performing the experiments can be utilized to generate the same results, and that these are considered as being covered by the following disclosure. Further discussion is presented of the specifics of certain tests performed on the samples for characterisation of its mechanical and physical properties.
1.1. Substrate preparation and morphological characterization
Metal discs (15 mm diameter, 1 mm thickness) made of c.p. Ti (commercially pure, ISO 5832-2, CH), Ti6A14V (ISO 5823-3, UK) as well as Ti6A17Nb (ISO 5832-11, CH) were used as substrates. Ti6A17Nb samples were machined and electro-eroded from hip implants, although this is presented purely as an example, samples of such a compound can be obtained by any normal manner. All samples were mechanically polished to 2000 grit followed by a chemical attack in a pickling solution containing (NH4)HF2, HNO3 and H2O, removing the top 30 μm and any possible change induced by mechanical polishing. For combining macro- and micro- roughness, some samples were sandblasted and chemically etched (pickled) before anodizing.
In order to contrast the α / α-β microstructure of the substrates, a TiAlNb and TiAlV substrate, respectively, was prepared as described above, additionally etched in a solution containing HF and HCl (Petzov Ti-M4) for approximately 60s. A c.p. Ti sample was contrasted by short electropolishing in 3M H2SO4 in methanol at 0°C.
1.2. Electrochemical spark anodisation
The following electrolytes were tested: 0. IM H2SO4 (0.1 M HS), 0.5M H2SO4 (0.5 M HS), 0.1 M H3PO4 (0.1 M HP), 0.5M H3PO4 (0.5 M HP), 0.1 M H2SO4 + 0.5M H3PO4 (0.1-0.5 M HSHP) and 0.5M H2SO4 + 0.5 M H3PO4 (0.5 M HSHP). Spark anodisations were performed at a starting temperature of 25 0C in a 1 L glass cell with water jacket, the temperature being controlled by a heater/cryostat circuit. A temperature increase up to 35°C was observed for the conditions with the largest anodisation currents. The working electrode was fixed to a Teflon® holder, facing up and leaving a small recess (d=0.5 mm) on the exposed surface (A=I.539 cm ). A Labview controlled power source (6 kW, Xantrex XDC 300-20) working in a 2-electrode setup with a cylindrical titanium mesh as counter electrode was used. Anodisation was performed potentio-dynamically with 5 V/s from OV up to the anodisation potential ΔEmax, followed by 60s
hold time at ΔEmax. The resulting current was precisely read back over selectable shunt resistors.
Before anodisation, samples were thoroughly rinsed with ultra-high purity water (18 MΩcm) and
transferred wet into the anodisation cell. ΔEmax was systematically varied in order to find optimal conditions in terms of oxide topography and morphology, uniformity and mechanical properties (low abrasion, good adhesion). Anodised samples were copiously rinsed with high purity water and dried under nitrogen flow. Whilst the above is presented as one system for performing spark anodisation, it would be clear to the skilled person that other systems and experimental set-ups could be utilised for generating the same results.
1.3. Tensile adhesion test
Tensile adhesion tests were carried out following DIN EN 582 using HTK Ultra Bond 100 as glue (measured tensile strength 110 MPa), hardening during a heat treatment with a maximum at 210 °C. The substrates with the anodized surface were glued between 2 sandblasted cylindrical steel supports that were fixed to the Epprecht-Multitest tensile testing machine. The backsides of the samples were roughened by grit-blasting to avoid failure at the interface backside/glue during the test. For a valid test, the failure upon load must occur within the oxide (cohesive) or at the interface substrate/oxide (adhesive). It was verified that the fracture morphology was not influenced by possible infiltration of the glue into open pores in the oxides. 1.4. Miller particle shedding test
In this test, carried out following ASTM G75, the anodized samples with 15 mm diameter were glued to a steel support connected to the moving arms of the Miller test equipment. Within one cycle of the test, the sample, rubbing against Neopren with Shore-Hardness 3, is moving linearly approximately 25 cm forth and 25 cm back. The mass loss, being a measure for the abrasion resistance of the coatings, is measured as a function of applied load and cycle frequency for a given number of cycles. This test was performed during 1000 cycles at a specific load of 0.113 N/mm2 at 0.78 Hz.
2. Results of performing the above experiments
In the following sections, the results of performing the experiments according to section 2.2 detailed above, on the various samples disclosed in section 2.1 are presented.
2.1 Microstructure
The microstructures of the substrates are presented in Fig. 1. The hexagonal α grains in
the c.p. titanium have diameters between 10-20 μm and are not preferentially oriented. A clear
orientation of the darker hexagonal α and the brighter cubic β phase, due to the forging of the
TiAlNb hip implant material, is presented in Fig. Ib. The plate-like α/β microstructure of TiAlV has smaller grains than in the TiAlNb alloy with no clear orientation (Fig. Ic). By EDX analysis an average of 6.2 w-% Al + 4.1 w-% Nb in the α and 3.0 w-% Al + 22.3 w-% Nb in the β phase
of the TiAlNb alloy was found. In the TiAlV alloy, the α phase contained 5.1 w-% Al + 3.0 w-%
V, whereas the β phase contained 4.4 w-% Al + 10.1 w-% V + 1.2 w-% Fe. This demonstrates
the role of V and Nb as β stabilizing and Al as α stabilizing elements. The iron contamination accumulated in the α phase of the Ti6A14V alloy can be explained by the tolerated maximum 0.3 w-% Fe in this alloy, according to ISO 5832-3 (1996).
2.2 Spark anodisation
The current density and the anodisation potential ΔE as a function of time for optimized anodisation conditions are shown in Fig. 2. In 0.5M H2SO4 (Fig. 2a), the behaviour of TiAlV differed significantly from the other materials. Its anodisation current increased very rapidly at potentials above 100 V, reaching a maximum at Emax (135 V) and then only slowly decreasing to a remaining high value during the hold-time. Also Ti and TiAlNb showed the current maximum when reaching Emax. However, the current then decreased rapidly towards almost zero for Ti and towards a low plateau value for TiAlNb, which was most probably due to the oxidation of H2O on top of the oxide. The anodisation of Ti and TiAlNb was found to be self-limiting in this electrolyte, whereas TiAlV continued to oxidize upon polarisation at Emax. At almost identical chosen anodisation potentials of 165V and 170 V for Ti and TiAlNb, respectively, Ti showed significantly lower currents. At low potentials however, Ti is the first substrate to exhibit sparking, followed by TiAlV and then TiAlNb, as can also be seen from the current increase in the initial stage of polarization. This behaviour at low potentials is identical upon anodisation in the electrolyte containing 0.5 M H2SO4 + 0.5 M H3PO3 (Fig. 2b). Sparking first appeared on Ti, then on TiAlV and TiAlNb. The maximum anodisation current for Ti, found before reaching the anodisation potential Emax, was even more significantly lower with respect to the alloys than in Fig. 2a, even so all three anodisation potentials were chosen quite close together. The maximum currents measured on the alloys were similar, TiAlV reaching a maximum when reaching Emax, whereas TiAlNb reproducibly exhibited a 2-peak behaviour with the maximum current shifted to the hold-time. All three substrates demonstrate a complete passivation within the hold-time. In both electrolytes, the spark anodisation current was clearly larger for Ti-alloys than for c.p. Ti, which points towards a lower (electro-)chemical stability of the α/β microstructure compared to
the Ti-α phase. It is interesting that the addition of phosphoric acid to 0.5 M H2SO4 resulted in lower anodisation currents in Fig. 2b compared to Fig. 2a, even so the anodisation potentials Emax were higher for the presented conditions in the mixture. Phosphoric acid seems to act as an "inhibitor" for spark anodisation of Ti-alloys.
2.3 Oxide morphology
The following sections provide details of the effects of different electrolytes on the structures of the samples.
2.3.1 H2SO4 containing electrolytes
In 0.1 M HS, a potential of at least 220 V is necessary to obtain oxides on Ti with uniformly distributed nano-pores, having pore diameters of around 100-200 nm. The pore size and simultaneously the roughness increases when going to higher potentials, leading to an increasing amount of protruding features and particles in the surface. In 0.5 M HS, the evolution of oxide morphology with growing potential was shifted to lower potentials compared to 0.1 M HS, due to the higher aggressiveness of this electrolyte. E.g., uniformly porous oxides on Ti appeared around 125-150 V. Generally, pores were found to be larger with higher electrolyte concentration. An example at 165 V is given in Fig. 3a. TiAlNb spark anodised in 0.1 M HS does not result in a homogeneous distribution of pores, even at potentials up to 250 V. Suitable morphologies are obtained in 0.5 M HS at potentials between 170-200 V, similar to the oxides on c.p. Ti (Fig. 3b). Further increasing the potential results in very rough and thick, but fragile and powdery looking surfaces. Spark anodisation of the TiAlV alloy in both sulphuric acid containing electrolytes behaves clearly differently from the other materials, as could be expected from the current-potential behaviour in Fig. 2a. Around 135 V in 0.5 HS, an oxide with small nano-pores was obtained (Fig. 3c). This oxide has a powdery, uneven appearance with fragile outstanding features and its colour is bright brownish and very different from the dark grey of the other materials. At 135 V, the surface is inhomogeneous, and at higher potentials the powdery aspect and brownish colour is more pronounced.
2.3.2 H3PO4 containing electrolytes
With applied voltages up to 300 V, hardly any sparking is observed in 0.1 M HP with all three materials. In 0.5 M HP, sparking at potentials above 250 V leads to larger pores than seen in 0.5 M HS. Pore density and pore distribution are inhomogeneous on the entire surface, leading to the conclusion that phosphoric acid alone does not provide satisfactory results.
2.3.3 H2SO4 - HsP O 4 containing electrolytes
The addition of phosphoric acid to sulphuric acid completely changes the oxide morphologies on all three materials compared with spark anodisation in H2SO4 alone. For a given potential, the anodisation current is lower in the mixture than in the electrolyte containing only the sulphuric acid part, H3PO4 acting as an inhibitor. Spark anodisation in 0.1-0.5 M HSHP results in similar oxides as obtained in 0.5 M HSHP, but again the lower acid concentration requires higher anodisation potentials and in general the final oxides morphology is less homogeneous. Spark anodisation of Ti in 0.5 M HSHP at 185 V leads to worm-like voids rather than pores (Fig. 3d). Above 200 V, the morphology changes to large pores with thick edges that seem to stand out of the surface, very similar to the TiUnite® surface [Hall J, Lausmaa J, WO0072776, WO0072777, WO0072775] on titanium. At 250 V, the pores have a diameter of approximately 5 μm. Almost identical oxide morphologies are found upon anodisation of both
Ti-alloys in 0.5 M HSHP. For TiAlNb, uniform worm-like structures ere found at potentials around 200-225 V, becoming again more pore-like at 250 V. For TiAlV, the formation of worms begins at around 175 V, to become also more pore-like at 250 V. Ideal conditions are found at with Emax of 200 V for TiAlNb (Fig. 3e) and 190 V for TiAlV (Fig. 3f).
Based on morphological considerations, the following conditions leading to homogeneous and suitable morphologies are chosen: Ti / 0.5 M HS / 165 V, Ti / 0.5 M HSHP / 185 V, TiAlNb / 0.5 M HS / 170 V, TiAlNb / 0.5 M HSHP / 200 V, TiAlV / 0.5 M HSHP / 190 V.
2.3.4 FIB cross-sections
The cross-section of a focused ion beam (FIB) milled oxide on TiAlNb with a porous morphology, grown in 0.5 M HS at 170 V and corresponding to Fig. 3b, is presented in Fig. 4a. Fig. 4b shows the cross-section of an oxide with a worm-like morphology on the same substrate, but grown in 0.5 M HSHP at 200 V (Fig. 3e). An average thickness of 2.21 ± 0.15 μm for the
porous and 3.39 ± 0.72 μm for the worm-like oxide was measured. The coating in Fig. 4a is very similar to oxides currently found upon spark anodisation of c.p. Ti and contains closed pores within the oxide, whereas the surface pores do not reach very deep. This may be the reason for the superficial bone in-growth observed in in-vivo tests with anodized Ti implants having a similar porous morphology, not showing an advantage over chemically treated Ti surfaces at a later stage of implantation. The cross-section of the oxide in Fig. 4b reveals approximately 2 μm deep channels between the oxide "worms", the oxide itself being almost free of closed porosity. In contrast to Fig1. 4a, the substrate was preferentially dissolved below the channels, leading to a significantly rougher interface metal/oxide compared to the porous oxide. The preferential dissolution of specific spots of the α/β microstructure in the presence of the acid mixture seems to be the reason for the observed oxide morphology. The oxide under the channels has a remaining thickness of 500-1000 nm. In spite of the dissolution of substrate material upon anodisation, the anodisation current was smaller during formation of the worm-like oxide (Fig. 2a) than for the porous oxide on TiAlNb (Fig. 2b). Both cross-sections reveal some nano-porosity at the interface metal/oxide.
2.4 Raman structure
The Raman spectra of c.p. Ti, TiAlNb and TiAlV spark anodized under optimized conditions in 0.5 M HS and 0.5 M HSHP are shown in Fig. 5. Crystalline titania can exist in the three polymorphs anatase, rutile and brookite. The main vibrational modes of anatase monocrystals are located at 144, 399, 519 and 639 cm'1, with 144 cm"1 being the strongest band. The Raman lines of monocrystalline rutile are found at 232, 447 and 612 cm"1. An intense and very intense band at 128 and 153 cm"1, a strong and medium band at 247 and 636 cm"1 as well as a shoulder peak at 396 cm"1 are reported for brookite.
The spectra in Fig. 5a for Ti anodized at 165 V in 0.5 M HS can be ascribed to a mixture of anatase and rutile, with anatase being the dominant phase. After spark anodisation of Ti at 185 V in the acid mixture, anatase structure (Fig. 5b) without any signs of rutile was observed. A strong rutile signature was found for TiAlNb oxidized at 170 V in 0.5 M HS (Fig. 5c). The spectra contains also anatase and brookite signals, with a strong brookite line at 157 cm"1, being too far from 144 cm"1 to be ascribed to anatase. A frequency blue shift and linewidth increase compared with single crystals is generally explained by non-stoichiometry by oxygen deficiencies, disorder induced by minor phases or pressure and phonon confinement effects. Anatase is clearly present at 518 cm"1, and the shoulders at approximately 396 and 638 cm"1 are due to anatase as well as brookite, having Raman active bands very close. Anodized in the acid mixture at 200 V (Fig. 5d), the brookite/anatase mixture becomes dominant, with a small amount of rutile still present. Very similar spectra as for TiAlNb are obtained for spark anodized TiAlV samples. Here, the rutile phase after anodisation in 0.5 M HS at 135 V is even more dominant, mixed with signals from the anatase and brookite phase (Fig. 5e). In the mixture anodized at 190 V, the obtained spectrum is virtually identical to Fig. 5d, showing a mixed brookite/anatase structure containing a small amount of rutile.
It is well known that for a given electrolyte, an increase in the anodisation potential results in higher anodisation currents and more vigorous sparking and hence, to an increased local temperature, enabling the formation of anatase, brookite and finally rutile phase, the latter being the high temperature phase of TiO2. The fact that the amount of rutile is clearly lower for anodized c.p. Ti than for the alloys in Fig. 5, can be explained by the considerably lower anodisation currents for Ti compared with the alloys (see Fig. 2) under the chosen conditions. The same argumentation can explain the difference in the amount of rutile between the alloys anodised in sulphuric acid or in the sulphuric/phosphoric acid mixture. Particularly interesting is the observation of the brookite phase within the coatings on Ti-alloys.
2.5 Chemical analysis with GD-OES
In Fig. 6, quantitative GD-OES depth profiles of c.p. Ti spark anodised under optimized conditions in 0.5 M HS (6a) and 0.5 M HSHP (6b) are shown, corresponding to the oxides in Fig. 3a and 3d and being a reference for the Ti-alloys. A stoichiometric oxide with Ti/O = 1 :2 with a rather sharp interface metal /oxide and a thickness of 2.04 μm, defined at the point where Ti/O = 1:1, is found in Fig. 6a. A carbon contamination of about 1 at-% throughout the oxide with an increase at the outer surface due to atmospheric contamination is found. The sulphur contamination of maximum 1.7 at-% is located mainly at the interface metal/oxide, possibly due to the mentioned interfacial nano-pores that might contain some electrolyte. However, no sulphur is detected in the first 200 nm of the oxide (insert in Fig. 6a). The sharp increase of oxygen and decrease of Ti towards the surface is systematically been observed and is most probably due to adsorbed humidity and OH-groups, which is also supported by an increase of the hydrogen signal (not shown). The 1.67 μm thick oxide grown in the acid mixture in Fig. 6b shows a spreading of surface and interface signals, due to the larger roughness of the obtained oxide morphology (Fig. 3d). Sulphur and carbon contamination are very similar to Fig. 6a, and an additional incorporation of 6-8 at-% P throughout the oxide is present, increasing to 12 at-% in the outermost 100 nm, possibly due to chemisorbed phosphates as supported by the simultaneous increase of the oxygen content. The higher oxide roughness compared with Fig. 6a results in a peak enlargement for species present at the surface, as seen for P and C in Fig. 6b.
The oxide grown on Ti6A17Nb in 0.5 M HS in Fig. 7a, corresponding to Fig. 3b and 4a, shows the same sulphur and carbon contamination as seen for c.p. Ti (Fig. 6a). Its interface is sharp due to the small roughness of the nano-porous oxide morphology. The amount of the alloying elements Al and Nb is clearly diminished within the oxide with respect to the substrate composition, yet both elements are still detectable in the outermost 200 nm (see insert Fig. 7a). The insert shows that Al remains with around 2 at-% and then decreases rapidly at the surface. From GD-OES depth profiling, a thickness of 2.24 μm is obtained, which is in excellent
agreement with an average thickness of 2.21 ± 0.15 μm measured at 7 spots in Fig. 4a. GD-OES depth profiling on the TiAlNb substrate spark anodized in 0.5 M HSHP in Fig. 7b, leading to the worm-like morphology in Fig. 3e and Fig. 4b, shows smeared signals at the surface and the interface, due to their larger roughness. From the GD-OES profile, a thickness of 3.14 μm is obtained (Ti/O = 1:1), which is again in good agreement with the average thickness of 3.39 ± 0.72 μm measured at 7 spots in Fig. 4b, in spite of the large thickness variations. The decrease of the alloying elements in the oxide is even more significant than in Fig. 6a. Within the first 200 nm of the oxide (see insert in Fig. 7b), the Nb content is below 0.5 at-%, and also Al decreases continuously to reach <0.5 at-% at the surface. Moreover, a significant and reproducible decrease in S contamination at the interface (<0.5 at-%) is found in the presence of phosphoric acid, possibly due to a lower interfacial porosity. A phosphorous content of about 8 at-% throughout the oxide is present, as seen already in Fig. 6b. This is not considered as contamination, but is regarded advantageous for the bioactivity of titanium oxides, especially when simultaneously present with Ca.
A sharp interface due to the good thickness uniformity thickness of the porous oxide (2.15 μm) and a decrease of the alloying elements Al and V, is measured for Ti6A14V anodized in 0.5 M HSHP (Fig. 8a). As observed before for Ti6A17Nb in Fig. 7a (insert), the Al content remains at 2-3 at-% before almost disappearing at the surface. Vanadium decreases to 0.5-1 at-% in the outer 200 nm of the oxide, but remains clearly detectable. The GD-OES depth profile of Ti6A14V spark anodized in the acid mixture (Fig. 8b) is very similar to Fig. 7b, with vanadium replacing niobium. Again the interfacial region appears larger than after anodisation in sulphuric acid, due to the enlarged interfacial roughness due to the local dissolution of the substrate upon spark anodisation. A thickness of 3.14 μm was found, identical to the oxide grown on TiAlNb in Fig. 7b. The aluminium concentration decreases throughout the oxide and is lower in the outer 200 nm compared with Fig. 8a. The vanadium content rapidly decreases within the oxide and is hardly detectable in the outermost oxide (see insert of Fig. 8b). This is of great interest for biomedical applications, where vanadium is considered toxic. The S contamination at the interface was significantly lower (< 1 at-%) compared with Fig. 8a, and P is present as seen for the other oxides grown in 0.5M HSHP. A small P peak before the interface metal/oxide, superposed to the phosphorous contained in the oxide and coinciding with the S contamination peak, supports the assumption of trapped electrolyte being present in a nano-porous zone close to the interface.
2.6. Mechanical properties Tensile adhesion tests according to DIN EN 582 are summarized in Table 1 for certain anodisation conditions. The adhesion strength of 40-50 MPa for the porous oxide morphology on c.p. Ti and TiAlNb from anodisation in 0.5 M HS is slightly better than the almost identical values around 34 MPa measured for the worm-like morphology formed in 0.5M HSHP mainly on Ti-alloys. A mixed adhesive/cohesive failure is observed for all conditions. Good adhesion of the coatings is expected, since a layer formed by plasma chemical oxidation of the substrate grows from inside and outside and does not contain an artificial interface as deposited coatings do. An adhesive/cohesive failure and an adhesion strength of 40 MPa is found for spark-anodized coatings on Ti6A14V in (NaPO3)6 containing alkaline electrolytes, using a shear strength test. A value of 37 ± 3 MPa and a cohesive failure is known for Ti6A14V spark anodized in Na2CO3 solution. For comparison, the minimal adhesion strength required for plasma-sprayed biomedical HA coatings according to ISO 13779-2 is 15 MPa, which is clearly lower than the present values. With respect to the large thickness variations in the worm-like oxide morphology on Ti-alloys (Fig. 4b), it is not surprising that the failure load for the mixed fracture is slightly lower compared to the porous morphology in Fig. 4a, where the perpendicular force is distributed more uniformly within the oxide. Good cohesion leading to low abrasion during implantation and during the life time of the implant, avoiding micron-sized particles that are difficult to phagocyte, is of fundamental importance. The Miller particle shedding test according to ASTM G75 allows for a quantitative investigation of the abrasion. Table 1 shows the mass loss of the present oxides in comparison to a pickled c.p. Ti reference surface and a plasma-sprayed Ti surface of 16 mm diameter (1 mm more than the other surfaces). All tested oxides perform at least four times better than the metallic c.p. Ti surface, leading to a larger mass loss during abrasion. The worm-like oxide on TiAlV shows particularly low abrasion, probably as a result of its hardness. The comparison to the approximately 250 μm thick commercial VPS-Ti surface (consisting of ~50 μm dense and -200 μm porous layer, 20-40 % open porosity, Rt = 150 μm) is even more dramatic, showing far better behaviour of the anodic coatings, probably also due to the smaller thickness.
2.7. Combination of grit-blasting and spark anodisation
A combination of micrometer and/or nanometre scale topographies on implantable orthopaedic devices is known to affect the cell behaviour in terms of cell adhesion, proliferation, differentiation, morphology, production of local factors etc. Spark anodisation was performed on grit-blasted substrates, followed by an additional pickling of the surface. In order to verify that the induced micro-roughness from grit-blasting is not significantly altered by the studied spark anodisation conditions due to a possible planarisation of the surface upon spark formation, the evolution of the relevant surface roughness parameters for c.p. Ti, TiAlNb and TiAlV after grit- blasting, chemical etching (pickling) and after spark anodisation was measured (Table 2). The pickling attack was found to reduce significantly the incorporated Al2O3 contamination on the surface from grit-blasting. In order to have the same initial surface chemistry before anodisation, the pickling attack was applied to all substrates in this study. The commonly cited roughness value Ra is slightly reduced during spark anodisation of grit-blasted substrates for all anodisation conditions and substrates, and also Rz follows this trend, however, enough roughness is left. The induced micro/nano roughness from to the porous or worm-like oxide morphologies can obviously not be accounted for with the applied profϊlometric method, having a good z-resolution of about 50 nm but an insufficient lateral resolution of 1 μm. Fig. 9 represents a 4-quadrant BSE detector micrograph of a Ti6A17Nb surface after grit-blasting, pickling and anodisation in 0.5 M HSHP at 200 V, representing at least two levels of roughness. 3. Discussion of the above results
As seen in Fig. 6-8, all investigated spark anodized surfaces contain a lower concentration of alloying elements Al, V and Nb than present in the substrate. On c.p. Ti, qualitative GD-OES depth profiles of Ca/P containing spark anodised show a more or less constant distribution of these elements and a phosphorous peak at the surface, possibly from adsorbed phosphates similar to Fig. 6b-8b. Based on XPS spectra, it is suggested that sulphated and phosphated titanium oxides (e.g. TiSO4, Ti2(SO4)3, TiPO4) are present. Based on the GD-OES analysis of the oxides, it is likely that sulphur is not reacting with titania and is solely present in the form of remaining electrolyte contamination in interfacial oxide pores, whereas P is mostly incorporated in the form of a phosphated titanium oxide. Based on XPS and SIMS depth profiles, a concentration level of typically 12-17 w-% Al, being significantly higher than expected from the bulk composition, is observed in native oxides on TΪ6A14V and Ti6A17Nb. Many findings for native or spark-less anodized oxides on Ti-alloys differ from the present findings for anodisation above the breakdown limit, which underlines the obvious differences in the formation mechanism in the presence of sparks and the locally very high temperature.
The depth profiles in Fig. 7 and 8 show that the amount of the biomedically problematic alloying elements and sulphur contaminations in spark anodized Ti-alloys can further be decreased when working in a mixture of sulphuric and phosphoric acid. This is clearly correlated to the different electrochemical behaviour in Fig. 2 when using the acid mixture, resulting in the specific morphological characteristics in Fig. 3 and 4 and probably a smaller interfacial porosity and decreased incorporation of electrolyte residuals. An oxide morphology on Ti-alloys similar to Fig. 3e & f and Fig. 4b is quite different from the nano- or micro-porous oxides (Fig. 3a-c) often reported, and seems particularly interesting with respect to the large topographical features in the range of 1-20 μm as well as the lack of protruding features and sharp edges. The worm-like topography is less pronounced on c.p. Ti, where it is mixed with porous structures. Hence, the particular and very similar oxide morphology forming on both Ti-alloys seems related to the presence of the alloying elements, but less to the α/β microstructure. A preferential dissolution of
the β phase of both Ti-alloys, being rich in V or Nb, would explain the measured decrease of Nb
and V, but not the decrease of Al being an α stabilizing element. Moreover, the preferential dissolution of one phase would lead to different oxides on Ti6A14V and Ti6A17Nb, due to the different substrate microstructure (Fig. Ib and Ic), which is in contradiction to the similarities in Fig. 3e and 3f. It is apparent that the higher anodisation currents for Ti-alloys in Fig. 2 are due to the purifying preferential dissolution of alloying elements, having an inferior electrochemical stability compared to TiO2. It seems most probable that the obtained round oxide features are the result of an electrolyte-specific vortex generated by micro-convection phenomena at the surface due to gas and heat formation upon spark discharge.
4. Conclusions
Spark anodisation of the α/β Ti alloys TΪ6A14V and Ti6A17Nb for biomedical surface preparation has been performed in various H2SO4, H3PO4 and mixed acid containing electrolytes and is compared to spark anodized c.p. Ti (α). Higher anodisation currents for the alloys compared to Ti indicate a lower electrochemical stability. A novel oxide morphology on the Ti- alloys featuring a "worm-like" topography, open cavities in the μm-range and a roughened interface metal/oxide was found when working in mixed H2SO4 and H3PO4 containing electrolytes, the formation of this special morphology being less pronounced on α-Ti. The oxides
with a typical feature size of 1-20 μm are very different from the well-known and reported nano- or micro-porous morphology commonly found after spark anodisation. By GD-OES depth profiling, the sparking process is found to produce oxides with significantly lower amounts of alloying elements than present in the substrates, which is highly interesting for biomedical applications. The worm-like oxides formed in the acid mixture show a particularly low amount of Al, V and Nb. The sulphur contamination from the electrolyte is strongly reduced in the presence OfH3PO4, while constant incorporation of around 8 at-% P throughout the oxide is measured. The particular morphological and chemical phenomena seem to be linked and could be the result of a specific solution vortex upon sparking in the acid mixture. From Raman, a mixture of anatase, rutile and brookite was identified in the coatings on Ti-alloys, where the latter has never been reported on spark anodized Ti materials. Bond strengths of 34 MPa for the worm-like and 40-50 MPa for the porous oxide morphology and mixed adhesive/cohesive failure are found. The oxides reveal an excellent abrasion resistance in a particle shedding test. It has further been shown that these anodic spark layers can readily be applied to grit-blasted and additionally etched surfaces, creating a surface topography with at least two levels of roughness. The described alloying element deficient oxides having a particular morphology suitable for incorporation of bone- growth stimulating agents are highly interesting for orthopaedic surfaces.

Claims

Claims:
1. A bone implant made from a valve metal alloy with at least one bone anchoring surface, whereby the bone anchoring surface is produced by an anodic oxidation (AO), characterized in that the concentration of the alloying elements in the oxide layer is less than 50 % of that in the base alloy.
2. A bone implant made from a valve metal alloy with at least one bone anchoring surface, whereby the bone anchoring surface is produced by an anodic oxidation (AO), characterized in that the continuous oxide-layer is partially intersected by multiple, narrow and elongated recesses.
3. A bone implant made from a valve metal alloy with at least one bone anchoring surface, whereby the bone anchoring surface is produced by an anodic oxidation (AO), characterized in that at least part of the crystalline structure of the oxide- layer consists of brookite.
4. A bone implant according to any of the preceding claims, whereby the bone anchoring surface is pre-treated by a mechanical (e.g. blasting) and/or chemical and/or electrochemical surface modification prior to the anodic oxidation (AO).
5. A bone implant according to claim 4, whereby the chemical attack prior to anodic oxidation (AO) is performed in a mixture containing ammonium bi-fluoride (NH4)HF2 and/or fluoric acid (HF) and/or nitric acid (HNO3) in aqueous solution during which the outermost 1-100 micrometers of the valve metal alloy substrate material are etched away.
6. A bone implant according to any of the preceding claims, whereby the valve metal alloy is based on at least one of the following elements: titanium (Ti), zirconium (Zr), niobium (Nb), tantalum (Ta) or hafnium (Hf).
7. A bone implant according to any of the preceding claims, whereby the alloying elements can be from the following list: aluminum (Al), vanadium (V), niobium (Nb), iron (Fe), zirconium (Zr), molybdenum (Mo), nickel (Ni), chromium (Cr), tin (Sn), tantalum (Ta), palladium (Pd), or hafnium (Hf).
8. A bone implant according to any of the preceding claims, whereby the anodic oxidation (AO) consists of spark discharge, spark anodization, spark oxidation, micro(-)arc oxidation (MAO), micro-arc discharge oxidation (MDO), micro- plasma oxidation (MPO), anodic spark deposition (ASD), plasma electrolytic oxidation (PEO), or anodic plasma-chemical treatment (APC).
9. A bone implant according to any of the preceding claims, whereby the anodic oxidation (AO) is performed in an alkaline electrolyte.
10. A bone implant according to claim 9, whereby the electrolytic bath is aqueous based and contains at least one of the following compounds: calcium hydroxide (Ca(OH)2), sodium hydroxide (NaOH), potassium hydroxide (KOH), magnesium hydroxide (Mg(OH)2), calcium dihydrogen phosphate Ca(H2PO4)2, or disodium hydrogen phosphate (Na2HPO4).
11. A bone implant according to any one of the claims 1 to 8, whereby the anodic oxidation (AO) is performed in an acidic electrolyte.
12. A bone implant according to claim 11, whereby the electrolytic bath comprises at least of one of the following acids in aqueous solution: sulfuric acid, phosphoric acid, nitric acid, hydrofluoric acid, formic acid, acetic acid, boric acid, maleic acid, malonic acid, oxalic acid, succinic acid, citric acid or propionic acid.
13. A bone implant according to claim 12, whereby the electrolytic bath contains at least two different acids in aqueous solution.
14. A bone implant according to claim 13, whereby the two acids are sulphuric acid and phosphoric acid.
15. A bone implant according to claim 14, whereby the concentration of the sulphuric acid is between 0.01 and 18 M, and the concentration of the phosphoric acid is between 0.01 and 14 M.
16. A bone implant according to claim 15, whereby the concentration of the sulphuric acid is further between 0.1 and 1 M, and the concentration of the phosphoric acid is further between 0.1 and 1 M.
17. A bone implant according to any of the preceding claims, whereby the anodic oxidation process is performed under application of a constant, increased or alternating (pulsed) potential or under application of a constant, increased or alternating (pulsed) current.
18. A bone implant according to any one of claims 15 to 17, whereby the anodic oxidation process is performed under potential control in a potential range between 0-400 Volts, preferably between 140-250 Volts.
19. A bone implant according to any of the preceding claims, whereby the concentration of the alloying elements at the outer surface of the oxide-layer is less than 25% of that in the base alloy.
20. A bone implant according to any of the preceding claims, whereby a titanium based alloy containing at least aluminum (Al) and vanadium (V) as alloying elements, features a gradually decreasing Al and V content from the metal/oxide interface to the outer surface.
21. A bone implant according to claim 20, whereby at least the outermost 200 nanometers of the oxide contains less than 0.5 atomic percent of vanadium (V) and less than 2 atomic percent of aluminum (Al).
22. A bone implant according to any one of the claims 1 to 19, whereby a titanium based alloy containing at least aluminum (Al) and niobium (Nb) as alloying elements, features a gradually decreasing Al and Nb content from the metal/oxide interface to the outer surface.
23. A bone implant according to claim 22, whereby at least the outermost 200 nanometers of the oxide contains less than 1 atomic percent of niobium (Nb) and less than 3 atomic percent of aluminum (Al).
24. A bone implant according to any of the preceding claims, whereby the oxide- layer features a nonuniform thickness in cross-section.
25. A bone implant according to any of the preceding claims, whereby the oxide- layer is substantially free of closed pores.
26. A bone implant according to any of the preceding claims, whereby the interface between the valve metal alloy and the oxide-layer is corrugated or convoluted in cross-section.
27. A bone implant according to any of the preceding claims, whereby the surface topography is corrugated or convoluted.
28. A bone implant according to any one of claims 24 to 27, whereby the oxide layer produced by anodic oxidation (AO) contains a compact barrier layer adjacent to the substrate.
29. A bone implant according to any of the preceding claims, whereby the oxide- layer thickness is between 500 nanometers and 15 micrometers.
30. A bone implant according to any of the preceding claims, whereby in general the length of the recesses is at least 4 times longer than their width.
31. A bone implant according to claim 30, whereby in general the width of the recesses is between 200 nanometers and 7 micrometers.
32. A bone implant according to any of the preceding claims, whereby in general the depth of the recesses is at least 50% of the mean oxide-layer thickness.
33. A bone implant according to any of the preceding claims, whereby at least part of the crystalline structure of the oxide-layer consists of anatase or rutile.
34. A bone implant according to any of the preceding claims, whereby at least part of the crystalline structure of the oxide-layer consists of anatase and rutile.
35. A bone implant according to any of the preceding claims, whereby at least one additional bioactive element or molecule is incorporated into the oxide-layer during the AO.
36. A bone implant according to claim 35, whereby at least one of the additional bioactive element or molecule is calcium (Ca), phosphate (P), a calcium- phosphate compound, a bone-growth-stimulating substance (such as proteins, growth factors, peptide sequences, or hormones), or an antibiotic.
37. A bone implant according to any of the preceding claims, whereby at least one additional bioactive element or molecule is infiltrated into the recesses of the oxide-layer after the AO.
38. A bone implant according to claim 37, whereby at least one of the additional bioactive element or molecule is calcium (Ca), phosphate (P), a calcium- phosphate compound, a bone-growth-stimulating substance (such as proteins, growth factors, peptide sequences, or hormones), or an antibiotic.
39. A bone implant according to any of the preceding claims, whereby at least one additional bioactive element or molecule is incorporated into a coating applied onto the surface of the oxide-layer after the AO.
40. A bone implant according to claim 39, whereby at least one of the additional bioactive element or molecule is calcium (Ca), phosphate (P), a calcium- phosphate compound, a bone-growth-stimulating substance (such as proteins, growth factors, peptide sequences, or hormones), or an antibiotic.
41. A bone implant according to any one of claims 37 to 40, whereby the infiltration into the recesses of the oxide-layer with at least one bioactive element or a coating applied onto the surface of the oxide layer after the AO containing at least one bioactive element, is achieved by a dipping, spraying, wet-chemical, sol-gel, electrochemical or plasma process.
42. A bone implant according to any of the preceding claims, whereby the surface of the oxide-layer is treated after the AO such that the surface becomes hydroxylated and hydrophilic.
43. A bone implant according to any of the preceding claims, whereby the surface of the oxide-layer is treated after the AO so as to have a surface contact angle of 45 degrees or less.
44. A bone implant according to claim 43, whereby the surface of the oxide-layer is treated after the AO so as to have a surface contact angle of 20 degrees or less.
45. A bone implant according to claim 44, whereby the surface of the oxide-layer is treated after the AO so as to have a surface contact angle of 10 degrees or less.
46. A bone implant according to claim 45, whereby the surface of the oxide-layer is treated after the AO so as to have a surface contact angle of 5 degrees or less.
47. An implant containing at least one bone anchoring surface according to any one of the preceding claims, where the implant is a dental implant, a spine implant, an orthopedic implant or an implant used for trauma applications.
PCT/EP2006/002239 2006-02-09 2006-03-10 Purified oxides with novel morphologies formed from ti-alloys WO2007090433A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2006001159 2006-02-09
EPPCT/EP2006/001159 2006-02-09

Publications (3)

Publication Number Publication Date
WO2007090433A2 true WO2007090433A2 (en) 2007-08-16
WO2007090433A8 WO2007090433A8 (en) 2007-09-27
WO2007090433A3 WO2007090433A3 (en) 2007-11-01

Family

ID=38109951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/002239 WO2007090433A2 (en) 2006-02-09 2006-03-10 Purified oxides with novel morphologies formed from ti-alloys

Country Status (1)

Country Link
WO (1) WO2007090433A2 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009147044A1 (en) * 2008-06-03 2009-12-10 Königsee Implantate und Instrumente zur Osteosynthese GmbH Electrochemically produced, biologically degradation stable, ductile and adhesive titanium oxide surface layer applied to titanium or titanium based alloys
DE102008026558A1 (en) 2008-06-03 2010-01-14 Königsee Implantate und Instrumente zur Osteosynthese GmbH Electrochemical immersion process in an aqueous electrolyte to produce a biologically degradable surface layer on bases of titanium or titanium-based alloys
CN102304746A (en) * 2011-09-26 2012-01-04 佳木斯大学 Polypyrrole calcium phosphate/magnesium oxide bioceramic coating and preparation method thereof
CN102397584A (en) * 2011-11-15 2012-04-04 东南大学 Medical magnesium alloy surface degradable composite protective film layer and preparation method thereof
CN102691087A (en) * 2011-03-24 2012-09-26 威高集团有限公司 Surface treatment method for improving bioactivity of medical beta-type titanium alloy surface
CN103194781A (en) * 2012-01-05 2013-07-10 中国科学院金属研究所 Bioactivity surface modification method used in degradable magnesium alloy
CN103272287A (en) * 2013-05-24 2013-09-04 华南理工大学 Biological medical degradable material and preparation method thereof
CN103272286A (en) * 2013-05-24 2013-09-04 华南理工大学 Controllable all-degradable biological material and preparation method thereof
CN103386148A (en) * 2013-06-19 2013-11-13 江苏科技大学 Bone repair material containing multi-element biocover and preparation method thereof
CN103451706A (en) * 2013-09-02 2013-12-18 吉林大学 Preparation method for directly generating hydroxyapatite-containing biological ceramic membrane on surface of titanium
CN104695005A (en) * 2015-03-13 2015-06-10 河北工业大学 Method for preparing orderly micro-nano structure on titanium substrate surface
CN105624762A (en) * 2016-01-15 2016-06-01 厦门大学 Method for preparing bioactive composite coating on surface of titanium or titanium alloy
CN105671612A (en) * 2015-08-21 2016-06-15 北京大学第三医院 Porous metal implant with micro-arc oxidation coating and preparation method
US9931348B2 (en) 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
FR3059342A1 (en) * 2016-11-28 2018-06-01 Institut De Recherche Technologique Materiaux, Metallurgie, Procedes PIECES WITH CERAMIC COATING ON TITANIUM OR TITANIUM ALLOY SURFACES, OBTAINED BY MICRO-ARC ANODIZATION AND ELECTROLYTE SUITABLE FOR OBTAINING THEM
US9999636B2 (en) 2010-12-10 2018-06-19 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
DE102017111784A1 (en) * 2017-05-30 2018-12-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Coated substrate with titanium-containing coating and modified titanium oxide coating
CN109609906A (en) * 2019-01-29 2019-04-12 西北工业大学 A kind of plasma discharge coupling method of modifying improving titanium alloy wear-resisting property
AU2018200062B2 (en) * 2010-12-10 2019-08-29 Rutgers, The State University Of New Jersey Implantable devices coated with insulin-mimetic agent composites and methods thereof
CN110484956A (en) * 2019-08-13 2019-11-22 洛阳双瑞精铸钛业有限公司 A kind of preparation method of titanium alloy drilling well workpiece high-wearing feature differential arc oxidation layer
CN111020545A (en) * 2019-12-13 2020-04-17 陕西易莱德新材料科技有限公司 Titanium material surface treatment method
CN111330580A (en) * 2020-03-10 2020-06-26 中国科学院山西煤炭化学研究所 Acid-resistant catalyst, preparation method thereof and application of acid-resistant catalyst in water-phase hydrogenation production of succinic acid
CN111467577A (en) * 2020-04-21 2020-07-31 王永芝 Medical metal bone implant material
CN113186579A (en) * 2021-04-20 2021-07-30 北京科技大学 Titanium alloy oral cavity restoration body surface whitening self-cleaning coating and preparation method thereof
CN113981296A (en) * 2021-12-24 2022-01-28 北京钢研高纳科技股份有限公司 Ti2AlNb-based alloy and preparation method and application thereof
CN114507893A (en) * 2022-01-14 2022-05-17 电子科技大学 High-hardness wear-resistant micro-arc oxidation coating electrolyte for tantalum alloy surface and preparation method thereof
CN114507892A (en) * 2022-01-14 2022-05-17 电子科技大学 Tantalum alloy self-lubricating wear-resistant and wear-reducing composite coating and preparation method thereof
CN114703530A (en) * 2022-04-28 2022-07-05 徐州工程学院 Method for compositely constructing samarium-doped hydroxyapatite gradient coating on surface of magnesium alloy by utilizing electrophoresis/micro-arc oxidation technology
CN115970057A (en) * 2022-09-09 2023-04-18 浙江科惠医疗器械股份有限公司 Petal-shaped TiO 2 Preparation method of nano-pore antibacterial coating
GB2613562A (en) * 2021-12-03 2023-06-14 Keronite International Ltd Use of chelating agents in plasma electrolytic oxidation processes

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232791A2 (en) * 1986-02-12 1987-08-19 AHC-Oberflächentechnik Friebe &amp; Reininghaus GmbH Metallic implant with a ceramics surface
US5354390A (en) * 1992-04-10 1994-10-11 Tavkozlesi Kutato Intezet Process for obtaining tissue-protective implants prepared from titanium or a titanium-base microalloy
EP0678300A1 (en) * 1993-11-09 1995-10-25 The Foundation For The Promotion Of Ion Engineering Bone substitute material and process for producing the same
WO2000072776A1 (en) * 1999-05-31 2000-12-07 Nobel Biocare Ab (Publ) Layer arranged on implant for bone or tissue structure, such an implant, and a method for application of the layer
WO2003003936A1 (en) * 2001-07-04 2003-01-16 Nobel Biocare Ab (Publ) Implant
WO2006004297A1 (en) * 2004-04-26 2006-01-12 Korea Institute Of Machinery And Materials Osseoinductive metal implants for a living body and producing method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232791A2 (en) * 1986-02-12 1987-08-19 AHC-Oberflächentechnik Friebe &amp; Reininghaus GmbH Metallic implant with a ceramics surface
US5354390A (en) * 1992-04-10 1994-10-11 Tavkozlesi Kutato Intezet Process for obtaining tissue-protective implants prepared from titanium or a titanium-base microalloy
EP0678300A1 (en) * 1993-11-09 1995-10-25 The Foundation For The Promotion Of Ion Engineering Bone substitute material and process for producing the same
WO2000072776A1 (en) * 1999-05-31 2000-12-07 Nobel Biocare Ab (Publ) Layer arranged on implant for bone or tissue structure, such an implant, and a method for application of the layer
WO2003003936A1 (en) * 2001-07-04 2003-01-16 Nobel Biocare Ab (Publ) Implant
WO2006004297A1 (en) * 2004-04-26 2006-01-12 Korea Institute Of Machinery And Materials Osseoinductive metal implants for a living body and producing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KERN ET AL: "Electrolytic deposition of titania films as interference coatings on biomedical implants: Microstructure, chemistry and nano-mechanical properties" THIN SOLID FILMS, ELSEVIER-SEQUOIA S.A. LAUSANNE, CH, vol. 494, no. 1-2, 3 January 2006 (2006-01-03), pages 279-286, XP005172021 ISSN: 0040-6090 *

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008026557A1 (en) 2008-06-03 2009-12-17 Königsee Implantate und Instrumente zur Osteosynthese GmbH Electrochemically produced, biodegradation-stable, ductile and adherent titanium oxide surface layer on titanium or titanium-based alloys
DE102008026558A1 (en) 2008-06-03 2010-01-14 Königsee Implantate und Instrumente zur Osteosynthese GmbH Electrochemical immersion process in an aqueous electrolyte to produce a biologically degradable surface layer on bases of titanium or titanium-based alloys
WO2009147044A1 (en) * 2008-06-03 2009-12-10 Königsee Implantate und Instrumente zur Osteosynthese GmbH Electrochemically produced, biologically degradation stable, ductile and adhesive titanium oxide surface layer applied to titanium or titanium based alloys
AU2018200062B2 (en) * 2010-12-10 2019-08-29 Rutgers, The State University Of New Jersey Implantable devices coated with insulin-mimetic agent composites and methods thereof
US9999636B2 (en) 2010-12-10 2018-06-19 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
CN102691087A (en) * 2011-03-24 2012-09-26 威高集团有限公司 Surface treatment method for improving bioactivity of medical beta-type titanium alloy surface
US9931348B2 (en) 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
CN102304746A (en) * 2011-09-26 2012-01-04 佳木斯大学 Polypyrrole calcium phosphate/magnesium oxide bioceramic coating and preparation method thereof
CN102397584A (en) * 2011-11-15 2012-04-04 东南大学 Medical magnesium alloy surface degradable composite protective film layer and preparation method thereof
CN103194781A (en) * 2012-01-05 2013-07-10 中国科学院金属研究所 Bioactivity surface modification method used in degradable magnesium alloy
CN103272286A (en) * 2013-05-24 2013-09-04 华南理工大学 Controllable all-degradable biological material and preparation method thereof
CN103272287A (en) * 2013-05-24 2013-09-04 华南理工大学 Biological medical degradable material and preparation method thereof
CN103386148A (en) * 2013-06-19 2013-11-13 江苏科技大学 Bone repair material containing multi-element biocover and preparation method thereof
CN103451706A (en) * 2013-09-02 2013-12-18 吉林大学 Preparation method for directly generating hydroxyapatite-containing biological ceramic membrane on surface of titanium
CN104695005A (en) * 2015-03-13 2015-06-10 河北工业大学 Method for preparing orderly micro-nano structure on titanium substrate surface
CN105671612A (en) * 2015-08-21 2016-06-15 北京大学第三医院 Porous metal implant with micro-arc oxidation coating and preparation method
CN105624762A (en) * 2016-01-15 2016-06-01 厦门大学 Method for preparing bioactive composite coating on surface of titanium or titanium alloy
FR3059342A1 (en) * 2016-11-28 2018-06-01 Institut De Recherche Technologique Materiaux, Metallurgie, Procedes PIECES WITH CERAMIC COATING ON TITANIUM OR TITANIUM ALLOY SURFACES, OBTAINED BY MICRO-ARC ANODIZATION AND ELECTROLYTE SUITABLE FOR OBTAINING THEM
DE102017111784A8 (en) * 2017-05-30 2019-02-21 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Coated substrate with titanium-containing coating and modified titanium oxide coating
DE102017111784A1 (en) * 2017-05-30 2018-12-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Coated substrate with titanium-containing coating and modified titanium oxide coating
CN109609906A (en) * 2019-01-29 2019-04-12 西北工业大学 A kind of plasma discharge coupling method of modifying improving titanium alloy wear-resisting property
CN110484956A (en) * 2019-08-13 2019-11-22 洛阳双瑞精铸钛业有限公司 A kind of preparation method of titanium alloy drilling well workpiece high-wearing feature differential arc oxidation layer
CN111020545A (en) * 2019-12-13 2020-04-17 陕西易莱德新材料科技有限公司 Titanium material surface treatment method
CN111330580A (en) * 2020-03-10 2020-06-26 中国科学院山西煤炭化学研究所 Acid-resistant catalyst, preparation method thereof and application of acid-resistant catalyst in water-phase hydrogenation production of succinic acid
CN111467577B (en) * 2020-04-21 2023-01-17 王永芝 Medical metal bone implant material
CN111467577A (en) * 2020-04-21 2020-07-31 王永芝 Medical metal bone implant material
CN113186579A (en) * 2021-04-20 2021-07-30 北京科技大学 Titanium alloy oral cavity restoration body surface whitening self-cleaning coating and preparation method thereof
CN113186579B (en) * 2021-04-20 2024-02-27 北京科技大学 Titanium alloy oral cavity restoration surface whitening self-cleaning coating and preparation method thereof
GB2613562A (en) * 2021-12-03 2023-06-14 Keronite International Ltd Use of chelating agents in plasma electrolytic oxidation processes
CN113981296A (en) * 2021-12-24 2022-01-28 北京钢研高纳科技股份有限公司 Ti2AlNb-based alloy and preparation method and application thereof
CN114507893A (en) * 2022-01-14 2022-05-17 电子科技大学 High-hardness wear-resistant micro-arc oxidation coating electrolyte for tantalum alloy surface and preparation method thereof
CN114507892B (en) * 2022-01-14 2023-11-24 电子科技大学 Tantalum alloy self-lubricating wear-resistant antifriction composite coating and preparation method thereof
CN114507893B (en) * 2022-01-14 2023-11-24 电子科技大学 Electrolyte for high-hardness wear-resistant micro-arc oxidation coating on tantalum alloy surface and preparation method thereof
CN114507892A (en) * 2022-01-14 2022-05-17 电子科技大学 Tantalum alloy self-lubricating wear-resistant and wear-reducing composite coating and preparation method thereof
CN114703530A (en) * 2022-04-28 2022-07-05 徐州工程学院 Method for compositely constructing samarium-doped hydroxyapatite gradient coating on surface of magnesium alloy by utilizing electrophoresis/micro-arc oxidation technology
CN114703530B (en) * 2022-04-28 2023-08-25 徐州工程学院 Method for compositely constructing samarium-doped hydroxyapatite gradient coating on magnesium alloy surface by utilizing electrophoresis/micro-arc oxidation technology
CN115970057A (en) * 2022-09-09 2023-04-18 浙江科惠医疗器械股份有限公司 Petal-shaped TiO 2 Preparation method of nano-pore antibacterial coating
CN115970057B (en) * 2022-09-09 2024-05-28 浙江科惠医疗器械股份有限公司 Petal-shaped TiO2Preparation method of nano-pore antibacterial coating

Also Published As

Publication number Publication date
WO2007090433A8 (en) 2007-09-27
WO2007090433A3 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
WO2007090433A2 (en) Purified oxides with novel morphologies formed from ti-alloys
Durdu et al. The tribological properties of bioceramic coatings produced on Ti6Al4V alloy by plasma electrolytic oxidation
Molaei et al. Improving surface features of PEO coatings on titanium and titanium alloys with zirconia particles: A review
Tang et al. Preparation and characterization of hydroxyapatite containing coating on AZ31 magnesium alloy by micro-arc oxidation
Duarte et al. Growth of aluminum-free porous oxide layers on titanium and its alloys Ti-6Al-4V and Ti-6Al-7Nb by micro-arc oxidation
Lausmaa Mechanical, thermal, chemical and electrochemical surface treatment of titanium
Liu et al. Formation characterization of hydroxyapatite on titanium by microarc oxidation and hydrothermal treatment
Fazel et al. A comparison of corrosion, tribocorrosion and electrochemical impedance properties of pure Ti and Ti6Al4V alloy treated by micro-arc oxidation process
Wang et al. Preparation and properties of titanium oxide film on NiTi alloy by micro-arc oxidation
Gopi et al. A comparative study on the direct and pulsed current electrodeposition of hydroxyapatite coatings on surgical grade stainless steel
Oh et al. Microstructural characterization of biomedical titanium oxide film fabricated by electrochemical method
US5211833A (en) Method for coating implants and surgical devices made of titanium and titanium alloys
Sowa et al. Surface characterisation and corrosion behaviour of niobium treated in a Ca-and P-containing solution under sparking conditions
Manjaiah et al. Effect of anodizing on surface integrity of Grade 4 titanium for biomedical applications
US7767250B2 (en) Bioceramic coating of a metal-containing substrate
He et al. Effect of hydrothermal treatment temperature on the hydroxyapatite coatings deposited by electrochemical method
Durdu et al. Characterization and bioactivity of hydroxyapatite-based coatings formed on steel by electro-spark deposition and micro-arc oxidation
Rakngarm et al. Electrochemical depositions of calcium phosphate film on commercial pure titanium and Ti–6Al–4V in two types of electrolyte at room temperature
Blawert et al. Plasma electrolytic oxidation/micro-arc oxidation of magnesium and its alloys
Wang et al. Enhanced corrosion resistance and in vitro bioactivity of NiTi alloys modified with hydroxyapatite-containing Al2O3 coatings
Huan et al. Porous NiTi surfaces for biomedical applications
Huang et al. Hydroxyapatite coatings produced on commercially pure titanium by micro-arc oxidation
Lee et al. Precipitation of bone-like apatite on anodised titanium in simulated body fluid under UV irradiation
Wu et al. Porous ceramic coating formed on 316L by laser cladding combined plasma electrolytic oxidation for biomedical application
SHI et al. Effects of electrolytic concentration on properties of micro-arc film on Ti6Al4V alloy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06723352

Country of ref document: EP

Kind code of ref document: A2